West Highlights Company Scientific and Regulatory Expertise at Notable Industry Meetings
"Our pharmaceutical and biopharmaceutical partners require expertise in specialized testing, analysis, and regulatory support to ensure their therapies are brought to market safely and efficiently," said
In advance of the
Preconference Workshopon Challenges and Patient Impact of Particles in Biologics April 30, 8:00 a.m.– 6:00 p.m., San Diego, Calif.
Particles in parenteral products, especially in protein containment, remains a hot topic, even though it has been discussed for many years. This workshop provided a lively discussion addressing questions related to particle formation, characterization tools and standards, to name a few.
During the workshop,
Fran DeGraziopresented a sub-session titled, Unique Considerations for Testing and Understanding Particle Loads from Primary Packaging Components.
DeGrazio and Paskiet will also participate in two important, upcoming
- Modernization of USP Packaging Standards for Glass and Elastomeric Components
June 19-20, Rockville, Md. June 20, 9:00 – 9:30 a.m.– <381> Elastomeric Components Used For Injectable Drug Products
Glass and elastomeric materials used in packaging systems must be shown to be suitable for their intended applications. To address these issues, USP is revising two existing USP-NF chapters <381> Elastomeric Closure for Injections and <660> Containers−Glass.
Diane Paskietwill present on the proposed revisions to <381> Elastomeric Components Used for Injectable Drug Products Packaging/Delivery Systems and provide background for developing additional chapters: <1381> Evaluation of Elastomeric Components Used in Pharmaceutical Packaging/Delivery Systems, <382> Elastomeric Closure Functionality in Injectable Pharmaceutical Packaging/Delivery Systems and <1382> Assessment of Elastomeric Closure Functionality in Injectable Pharmaceutical Packaging/Delivery Systems.
- Control and Determination of Visible and Sub-Visible Particulate Matter in Biologics
June 26-27, Rockville, Md. June 27, 8:30 a.m.– Particulate Matter in Biologics Originating from Packaging Components: Occurrence and Control Measures
Part of a session on "Manufacturing Control of Particulate Matter," this presentation will describe current particle measurement technologies and sample preparation techniques applicable to packaging components. Visible and sub-visible particles from primary and secondary packaging components will be discussed and case studies will illustrate outcomes of particle investigations and examples of quality control data.
Additionally, Paskiet will co-chair and DeGrazio will present this fall at a
- 2017 PDA Container Closure, Devices and Delivery Systems:
Compatibility and Material Safety Workshop October 2-3, Washington, D.C. October 3, 8:30 – 10:00 a.m.– Impact and Consideration of Pharmaceutical Packaging on Particulates
With the patient in mind, this workshop will focus on the most current and relevant topics in the world of container closures for device and delivery systems as it relates to material compatibility and safety.
Fran DeGraziowill present this session on the impact of particulates on injectable drug packaging.
In addition to regularly presenting at industry events,
For more information on these upcoming presentations, West products and services, and technical expertise, please visit us online at www.westpharma.com.
West and the diamond logo are registered trademarks of
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/west-highlights-company-scientific-and-regulatory-expertise-at-notable-industry-meetings-300450188.html